|
1
|
Lin JD, Hsueh C and Chao TC: Long-term
follow-up of the therapeutic outcomes for papillary thyroid
carcinoma with distant metastasis. Medicine (Baltimore).
94:e10632015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng XG, Chen ZF, Zhang KJ, Wang PG, Liu
ZM, Chen ZJ, Hou GY and Niu M: VEGF Trapon inhibits tumor growth in
papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 19:235–240.
2015.PubMed/NCBI
|
|
4
|
Nikiforov YE and Nikiforova MN: Molecular
genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol.
7:569–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cabanillas ME, McFadden DG and Durante C:
Thyroid cancer. Lancet. 388:2783–2795. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Todorović L, Stanojević B, Mandušić V,
Petrović N, Živaljević V, Paunović I, Diklić A, Saenko V and
Yamashita S: Expression of VHL tumor suppressor mRNA and miR-92a in
papillary thyroid carcinoma and their correlation with clinical and
pathological parameters. Med Oncol. 35:172018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han C, Zheng W, Ge M, Wang K, Xiang Y and
Wang P: Downregulation of cyclin-dependent kinase 8 by
microRNA-148a suppresses proliferation and invasiveness of
papillary thyroid carcinomas. Am J Cancer Res. 7:2081–2090.
2017.PubMed/NCBI
|
|
8
|
Li H, Zhao L, Zhang Z, Zhang H, Ding C and
Su Z: Roles of microRNA let-7b in papillary thyroid carcinoma by
regulating HMGA2. Tumour Biol. 39:10104283177192742017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al:
The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: MicroRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:(Database Issue).
D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chou CK, Liu RT and Kang HY:
MicroRNA-146b: A novel biomarker and therapeutic target for human
papillary thyroid cancer. Int J Mol Sci. 18(pii): E6362017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Niu S, Ma X, Zhang Y, Liu YN, Chen X, Gong
H, Yao Y, Liu K and Zhang X: MicroRNA-19a and microRNA-19b promote
the malignancy of clear cell renal cell carcinoma through targeting
the tumor suppressor RhoB. PLoS One. 13:e01927902018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng Y, Shen X, Jiang H, Chen Z, Wu J, Zhu
Y, Zhou Y and Li J: MiR-188-5p suppresses gastric cancer cell
proliferation and invasion via targeting ZFP91. Oncol Res.
2018.(Epub ahead of print). View Article : Google Scholar
|
|
14
|
Zhang Y, Jiang F, He H, Ye J, Mao X, Guo
Q, Wu SL, Zhong W, Wu CL and Lin N: Identification of a novel
microRNA-mRNA regulatory biomodule in human prostate cancer. Cell
Death Dis. 9:3012018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perdas E, Stawski R, Nowak D and Zubrzycka
M: The role of miRNA in papillary thyroid cancer in the context of
miRNA Let-7 family. Int J Mol Sci. 17(pii): E9092016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hua K, Jin J, Zhang H, Zhao B, Wu C, Xu H
and Fang L: MicroRNA-7 inhibits proliferation, migration and
invasion of thyroid papillary cancer cells via targeting CKS2. Int
J Oncol. 49:1531–1540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Celano M, Rosignolo F, Maggisano V, Pecce
V, Iannone M, Russo D and Bulotta S: MicroRNAs as biomarkers in
thyroid carcinoma. Int J Genomics. 2017:64965702017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Deng Y and Fu X: MiR-509-5p
suppresses the proliferation, migration, and invasion of non-small
cell lung cancer by targeting YWHAG. Biochem Biophys Res Commun.
482:935–941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma N, Zhang W, Qiao C, Luo H, Zhang X, Liu
D, Zang S, Zhang L and Bai J: The tumor suppressive role of
MiRNA-509-5p by targeting FOXM1 in non-small cell lung cancer. Cell
Physiol Biochem. 38:1435–1446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su Z, Chen D, Zhang E, Li Y, Yu Z, Shi M,
Jiang Z, Ni L, Yang S, Gui Y, et al: MicroRNA-509-3p inhibits
cancer cell proliferation and migration by targeting the
mitogen-activated protein kinase kinase kinase 8 oncogene in renal
cell carcinoma. Mol Med Rep. 12:1535–1543. 2015.PubMed/NCBI
|
|
21
|
Zhang G, Liu Z, Han Y, Wang X and Yang Z:
Overexpression of miR-509 increases apoptosis and inhibits invasion
via suppression of tumor necrosis factor-α in triple-negative
breast cancer Hs578T cells. Oncol Res. 24:233–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang X, Mao H and Lv Z: MicroRNA role in
thyroid cancer pathogenesis. Front Biosci (Landmark Ed).
18:734–739. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JC, Gundara JS, Glover A, Serpell J
and Sidhu SB: MicroRNA expression profiles in the management of
papillary thyroid cancer. Oncologist. 19:1141–1147. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aragon Han P, Weng CH, Khawaja HT,
Nagarajan N, Schneider EB, Umbricht CB, Witwer KW and Zeiger MA:
MicroRNA expression and association with clinicopathologic features
in papillary thyroid cancer: A systematic review. Thyroid.
25:1322–1329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du P, Luan X, Liao Y, Mu Y, Yuan Y, Xu J
and Zhang J: MicroRNA-509-3p inhibits cell proliferation and
invasion via downregulation of X-linked inhibitor of apoptosis in
glioma. Oncol Lett. 15:1307–1312. 2018.PubMed/NCBI
|
|
27
|
Sun J, Li J, Zhang W, Zhang J, Sun S, Li
G, Song H and Wan D: MicroRNA-509-3p inhibits cancer cell
proliferation and migration via upregulation of XIAP in gastric
cancer cells. Oncol Res. 25:455–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Li Y, Wan L, Chen R and Chen F:
miR-509-5p inhibits cellular proliferation and migration via
targeting MDM2 in pancreatic cancer cells. Onco Targets Ther.
10:4455–4464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hiramoto H, Muramatsu T, Ichikawa D,
Tanimoto K, Yasukawa S, Otsuji E and Inazawa J: miR-509-5p and
miR-1243 increase the sensitivity to gemcitabine by inhibiting
epithelial-mesenchymal transition in pancreatic cancer. Sci Rep.
7:40022017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Underhill DA: Genetic and biochemical
diversity in the Pax gene family. Biochem Cell Biol. 78:629–638.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Georgala PA, Carr CB and Price DJ: The
role of Pax6 in forebrain development. Dev Neurobiol. 71:690–709.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanson IM: PAX6 and congenital eye
malformations. Pediatr Res. 54:791–796. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, Li Y, Liu Y, Xie P, Li F and Li G:
PAX6, a novel target of microRNA-7, promotes cellular proliferation
and invasion in human colorectal cancer cells. Dig Dis Sci.
59:598–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao Y, Lu G, Ke X, Lu X, Wang X, Li H,
Ren M and He S: miR-488 acts as a tumor suppressor gene in gastric
cancer. Tumour Biol. 37:8691–8698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang BS, Luo QZ, Han Y, Huang D, Tang QP
and Wu LX: MiR-223/PAX6 axis regulates glioblastoma stem cell
proliferation and the chemo resistance to TMZ via regulating
PI3K/Akt pathway. J Cell Biochem. 118:3452–3461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia X, Yin W, Zhang X, Yu X, Wang C, Xu S,
Feng W and Yang H: PAX6 overexpression is associated with the poor
prognosis of invasive ductal breast cancer. Oncol Lett.
10:1501–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao X, Yue W, Zhang L, Ma L, Jia W, Qian
Z, Zhang C and Wang Y: Downregulation of PAX6 by shRNA inhibits
proliferation and cell cycle progression of human non-small cell
lung cancer cell lines. PLoS One. 9:e857382014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meng Q, Dai M, Nie X, Zhang W, Xu X, Li J,
Mu H, Liu X, Qin L, Zhu X, et al: MicroRNA-19 contributes to the
malignant phenotypes of osteosarcoma in vitro by targeting Pax6.
Tumour Biol. 40:10104283177447042018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li X, Yang L, Shuai T, Piao T and Wang R:
MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1
and PAX6 expression. Biomed Pharmacother. 82:247–255. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Meng B, Wang Y and Li B: Suppression of
PAX6 promotes cell proliferation and inhibits apoptosis in human
retinoblastoma cells. Int J Mol Med. 34:399–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Malik AY and Foster C: The revised
Declaration of Helsinki: Cosmetic or real change? J R Soc Med.
109:184–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
